First report of a randomized phase II trial of multi-epitope vaccination with melanoma peptides for cytotoxic T cells and helper T cells in patients with metastatic melanoma: An Eastern Cooperative Oncology Group Study (E1602)

8508 Background: This multicenter randomized trial was designed to evaluate, in advanced previously treated melanoma, whether melanoma helper peptides augment CD8+ T-cell responses to a melanoma va...